Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Advantest’s VOICE 2024 Draws Record Attendance in San Diego
-
Global Study Finds Only 22% Effectively Using Gen AI Across All Business Functions
-
Boyden UK Names Richard Waddell as Managing Partner for Leadership Consulting Practice
-
GXO recognized by Ex-Forces in Business for support of British veterans and reservists
-
Update regarding Debt Funding from A & T Investments SARL
-
Nexans and SNCF Réseau revolutionize rail safety with an innovative superconducting fault current limiter
-
Transactions by persons discharging managerial responsibilities and persons closely associated with them
-
Monika Nachyła starts taking the position of a member of the Supervisory Council of Šiaulių Bankas AB
-
Quadient S.A. - 2023 dividend payment timeline
-
Bioxodes meets first Phase 2a patient enrollment milestone with BIOX-101 in intracerebral hemorrhagic stroke
-
ChainSwap Uses Chainlink CCIP To Power Cross-Chain Swaps, Soon To Be Instant And Available Through Telegram Bot
-
Completion of the Second Tranche of Stellantis 2024 Share Buyback Program and Weekly Report (June 21-26, 2024)
-
Director/PDMR Shareholding
-
Disclosure of New Directorship
-
Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi
-
Ashley Paul & Luv Foundation (UK) Announce 'HEARTS UP' UK TOUR
-
Nokia enters into an agreement with the French State regarding the sale of leading submarine networks business ASN
-
Purchase of Own Securities and Total Voting Rights
-
Ensurge Delivers First Shipment of Solid-State Lithium Microbatteries to Leading Medical Device Company
-
Fingerprints supports Valid in launching biometric payment card in Brazil
-
Riber: Order for a Compact 21 research platform in France
-
Changes in the Supervisory Council of AS Tallinna Vesi
-
Transaction in Own Shares
-
Multitude SE: Repurchase of own shares 26.06.2024
-
BGHL (GBP): NAV(s)
-
Sampo plc’s share buybacks 26 June 2024
-
BGHL (EUR): NAV(s)
-
Start of Day Message
-
Statkraft sharpens strategy for further growth
-
TGS Announces New Mutli-Client Onshore 3D Seismic Survey In The Appalachian Basin
-
Technip Energies acquires technology from Shell to accelerate bio-polyester production
-
Roche expands access to cervical cancer screening tools with two new WHO prequalification designations, including HPV self-collection
-
CARBIOS and Zhink Group enter official discussions for long-term partnership to build PET biorecycling industrial capacities in China in view of first licensing agreement for 50k tons per year
-
Save the date in your event calendar: Join and learn about the new era of cancer care at the ICPO Theranostics Virtual Summit, Nov 14 -15, 2024
-
Qianhai Leads the Cooperation of Shenzhen and Hong Kong
-
Marubeni Corporation and Lithia & Driveway Make a Strategic Investment in Wheels, Partnering with Apollo Funds
-
Marubeni Corporation and Lithia & Driveway Make a Strategic Investment in Wheels, Partnering with Apollo Funds
-
OKX Announces Launch of ‘Zeta Airdrop’ Campaign Featuring 10,000 ZETA in Rewards
-
Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Direct Digital, Hertz, Humana, and Roblox and Encourages Investors to Contact the Firm
-
BranchOut Food Prices $1.4 Million Follow-On Public Offering
-
Announcement Regarding Filing of Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
-
Else Nutrition Announces US$2 Million Offering of Units Priced At-The-Market
-
NASP Applauds the Senate Finance Chairman for Working to Address Unfair PBM Practices
-
-
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
-
EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
-
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
-
PyroGenesis Provides Update Regarding Receipt of $4.1 Million Payment
-
Dr. Kevin Cross Is Featured as a Top Doc in Philadelphia
